Randomized controlled trial evaluating the benefit of the App-based Clinical Decision Support System for the management of venous thromboembolism

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

TCTR

Registry ID

TCTR20241117004

Enrollment

126

Registered

2024-11-17

Start date

2023-01-27

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

venous thromboembolism venous thromboembolism, CDSS, anticoagulant, prescription error, warfarin

Interventions

Used App-based CDSS,None used App-based CDSS

Experimental No treatment,No Intervention No treatment

App-based CDSS,Control

Eligibility

Sex/Gender

All

Age

20 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Aged 20 years or older 2. Trainees in one of the following categories: medical student (4th, 5th, 6th clinic), intern, internal medicine resident, or hematology fellow.

Exclusion criteria

Exclusion criteria: Those who refused to participate or had previously tested or used the app-based CDSS were excluded.

Design outcomes

Primary

Measure	Time frame
To evaluate the accuracy of medical personnel's decisions in patient care using the application. 30 mins Use questionnaire for expert evaluation CDSS	—

Secondary

Measure	Time frame
To assess the satisfaction of medical personnel with the application. 15 mins Use questionnaire for users CDSS	—

Countries

Thailand

Contacts

Public ContactChatree ChaiAdisaksopha

Division of Hematology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand

chatree.chai@cmu.ac.th053935488

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026